Lidocaine and ropivacaine are routinely used for subcutaneous local anesthesia in pacemaker implantation, combined with fentanyl needle micropump to maintain injection. However, these simple local anesthesia methods often fail to produce sufficient analgesia in deeper subcutaneous areas. This study adopted ultrasound-guided precision nerve block anesthesia. Through contrast analysis, it was clear
Conditions
Interventions
Treatment group:nerve block anesthesia
Sponsors
The First Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. The selected patients were aged between 45 and 75 years old, with no gender restrictions. 2. Indications for pacemaker implantation (including single-chamber pacemakers, dual-chamber pacemakers, ICDs, and CRT/D);
Exclusion criteria
Exclusion criteria: 1.Patients who are unable to maintain a supine position for an extended period of time or exhibit challenges in cooperating with anesthesia, such as individuals with cognitive impairments, psychiatric disorders, and communication difficulties. 2.Potential complications include infections, both superficial and deep-seated, at the site of puncture. 3.The presence of peripheral neuropathy, including sensory disturbances, motor disorders, autonomic dysfunction, etc., in combination. 4.Complications of coagulation dysfunction; 5.Prior medical record of hypersensitivity reactions to anesthetics; 6.Patients diagnosed with hypertension, whose blood pressure remains persistently elevated above 180/110 mmHg (grade 3), either uncontrolled by medication or despite medication control. 7.Patients with abnormal thyroid function who have not received pharmacological treatment or whose levels of free T3, T4, and TSH have not normalized following treatment. 8.Patients with diabetes complicated by ketoacidosis or hyperosmolar coma, presenting severe uncontrolled diabetic foot infections. 9.Patients diagnosed with chronic renal insufficiency and a creatinine clearance rate below 30 ml/min. 10.Patients diagnosed with malignant tumors or other chronic illnesses, whose prognosis indicates a life expectancy of less than one year. 11.Patients with decompensated cirrhosis, or gastrointestinal disorders that are prone to malnutrition, such as active ulcers, chronic pancreatitis, chronic intestinal fistula, Crohn's disease, and ulcerative colitis. 12.The severe anemia (<60g/L) is caused by various factors and the underlying etiology has not been corrected. 13.The presence of severe lung diseases, such as silicosis, pulmonary damage resulting from various causes, and advanced chronic bronchitis and emphysema, is indicated by pulmonary function tests showing severe obstructive or mixed ventilation dysfunction. 14.A definitively diagnosed primary or secondary skeletal muscle disorder, such as myasthenia gravis, mitochondrial myopathy, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The intensity of pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| frequency of body movements;intraoperative anesthetic dosage;complications;frequency of gastrointestinal symptoms.;Operation duration;Postoperative use of analgesic medications; | — |
Countries
China
Contacts
Public ContactChen Xiao
The First Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed